Press Release | Newsroom | Medtronic | Medtronic Announces 2016 Institutional Investor and Analyst Meeting and Webcast

Press Release

Printer Friendly Version View printer-friendly version
Download PDF Download PDF
<< Back
Medtronic Announces 2016 Institutional Investor and Analyst Meeting and Webcast

DUBLIN - May 10, 2016 - Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Meeting on Monday, June 6, 2016, in New York City from 8:00 a.m. to approximately 3:15 p.m. Eastern Daylight Time. The meeting will include remarks from the Medtronic executive management team on the company's plans for delivering consistent and reliable revenue growth, strong operating and financial leverage, significant accessible free cash flow, and strategic capital deployment, all of which are expected to result in long-term value creation for its shareholders.

Medtronic will host a webcast of the meeting to provide access to all interested stakeholders. The webcast can be accessed by clicking on the Investor Events link at on June 6, 2016. Slides from the meeting will be available to those viewing the webcast. Within 24 hours of the webcast, a replay including presentation slides will be available by clicking on the Investor Events link at Institutional investors seeking more information about the meeting should contact Tracy McCartney in Medtronic Investor Relations by e-mail at or by phone at +1-763-505-2692.

About Medtronic
Medtronic plc (, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.



Fernando Vivanco
Public Relations

Ryan Weispfenning
Investor Relations